Supriya Lifescience Ltd. | Mid-cap | Healthcare
₹688.80
1.20%
| Supriya Lifescience Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 7.0B
Gross Profit 4.9B 69.68%
Operating Income 2.4B 34.51%
Net Income 1.9B 26.99%
EPS (Diluted) ₹23.35

Balance Sheet Metrics

Total Assets 11.1B
Total Liabilities 1.2B
Shareholders Equity 10.0B
Debt to Equity 0.12

Cash Flow Metrics

Operating Cash Flow 1.9B
Free Cash Flow 23.0M

Revenue & Profitability Trend

Supriya Lifescience Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 7.0B 5.6B 4.5B 5.2B 3.9B
Cost of Goods Sold 2.1B 2.8B 2.3B 2.3B 1.5B
Gross Profit 4.9B 2.8B 2.2B 2.9B 2.3B
Operating Expenses 1.4B 468.3M 437.0M 364.4M 341.4M
Operating Income 2.4B 1.6B 1.2B 2.0B 1.6B
Pre-tax Income 2.5B 1.7B 1.2B 2.1B 1.7B
Income Tax 605.2M 465.8M 336.3M 554.4M 437.2M
Net Income 1.9B 1.2B 898.6M 1.5B 1.2B
EPS (Diluted) ₹23.35 ₹14.80 ₹11.16 ₹18.86 ₹48.38

Income Statement Trend

Supriya Lifescience Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 4.4B 4.0B 4.6B 5.0B 2.7B
Non-Current Assets 6.8B 5.2B 3.6B 2.4B 1.8B
Total Assets 11.1B 9.2B 8.2B 7.3B 4.5B
Liabilities
Current Liabilities 821.6M 768.9M 957.8M 997.0M 1.5B
Non-Current Liabilities 333.9M 289.8M 250.4M 193.8M 308.6M
Total Liabilities 1.2B 1.1B 1.2B 1.2B 1.8B
Equity
Total Shareholders Equity 10.0B 8.2B 7.0B 6.2B 2.7B

Balance Sheet Composition

Supriya Lifescience Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 2.5B 1.7B 1.2B 2.1B 1.7B
Operating Cash Flow 1.9B 1.4B 654.2M 1.0B 973.8M
Investing Activities
Capital Expenditures -1.6B -1.5B -1.1B -598.2M -468.0M
Investing Cash Flow -1.6B -1.5B -1.1B -598.2M -468.0M
Financing Activities
Dividends Paid -64.4M -48.3M -48.3M -43.9M -39.6M
Financing Cash Flow -64.4M -214.5M -60.0K 1.5B -82.5M
Free Cash Flow 23.0M -323.5M -443.0M -111.0M 276.5M

Cash Flow Trend

Supriya Lifescience Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 28.76
Forward P/E 22.29
Price to Book 5.39
Price to Sales 7.75
PEG Ratio 0.50

Profitability Ratios

Profit Margin 26.99%
Operating Margin 33.41%
Return on Equity 20.74%
Return on Assets 14.77%

Financial Health

Current Ratio 5.32
Debt to Equity 0.54
Beta 0.23

Per Share Data

EPS (TTM) ₹23.33
Book Value per Share ₹124.44
Revenue per Share ₹86.52

Financial data is updated regularly. All figures are in the company's reporting currency.